CAM
OSIR

Cormorant Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Cormorant Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-107,800
Closed -$1.73M – 57
2013
Q4 		$1.73M Buy
+107,800
New +$1.72M 0.5% 30

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Cormorant Asset Management's OSIR Position: Q1 2014 in Review

Cormorant Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2014, closing a stake of 107,800 shares — an estimated $1.73M sold.

Cormorant Asset Management first reported a position in OSIR in Q4 2013 and held it in 1 quarter. The position peaked at $1.73M in Q4 2013. 63 funds tracked by Wall St. Rank hold OSIR as of Q1 2014.

  • Cormorant Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Cormorant Asset Management sold 107,800 Osiris Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $1.73M.
  • Cormorant Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Cormorant Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.73M in Q4 2013.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Cormorant Asset Management's 13F filing for Q1 2014, filed 15 May 2014.